NCT01386528 - Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 7, 2012

Primary Completion Date

December 1, 2013

Study Completion Date

December 1, 2013

Conditions

Congenital Bleeding DisorderHaemophilia B

Interventions

DRUG

nonacog beta pegol

The patients will receive nonacog beta pegol at screening just prior to and during surgical intervention, administered intravenously (into the vein).

Trial Locations (41)

100

Novo Nordisk Investigational Site, Taipei

1000

Novo Nordisk Investigational Site, Skopje

1090

Novo Nordisk Investigational Site, Vienna

2193

Novo Nordisk Investigational Site, Parktown Johannesburg

10400

Novo Nordisk Investigational Site, Bangkok

13210

Novo Nordisk Investigational Site, Syracuse

20007

Novo Nordisk Investigational Site, Washington D.C.

20124

Novo Nordisk Investigational Site, Milan

28046

Novo Nordisk Investigational Site, Madrid

30625

Novo Nordisk Investigational Site, Hanover

30912

Novo Nordisk Investigational Site, Augusta

35392

Novo Nordisk Investigational Site, Giessen

38010

Novo Nordisk Investigational Site, Kayseri

42090

Novo Nordisk Investigational Site, Konya

46026

Novo Nordisk Investigational Site, Valencia

47051

Novo Nordisk Investigational Site, Duisburg

50134

Novo Nordisk Investigational Site, Florence

50400

Novo Nordisk Investigational Site, Kuala Lumpur

52242

Novo Nordisk Investigational Site, Iowa City

53127

Novo Nordisk Investigational Site, Bonn

69003

Novo Nordisk Investigational Site, Lyon

77030

Novo Nordisk Investigational Site, Houston

90027

Novo Nordisk Investigational Site, Los Angeles

94143

Novo Nordisk Investigational Site, San Francisco

94270

Novo Nordisk Investigational Site, Le Kremlin-Bicêtre

300011

Novo Nordisk Investigational Site, Timișoara

GR-11527

Novo Nordisk Investigational Site, Athens

634 8522

Novo Nordisk Investigational Site, Kashihara-shi, Nara

216-8511

Novo Nordisk Investigational Site, Kawasaki-shi, Kanagawa

466 8560

Novo Nordisk Investigational Site, Nagoya-shi, Aichi

663 8051

Novo Nordisk Investigational Site, Nishinomiya-shi

167 0035

Novo Nordisk Investigational Site, Suginami-ku, Tokyo

108-8639

Novo Nordisk Investigational Site, Tokyo

3584 CX

Novo Nordisk Investigational Site, Utrecht

06500

Novo Nordisk Investigational Site, Ankara

RG24 9NA

Novo Nordisk Investigational Site, Basingstoke

CF14 4XW

Novo Nordisk Investigational Site, Cardiff

NW3 2QG

Novo Nordisk Investigational Site, London

SE1 7EH

Novo Nordisk Investigational Site, London

M13 9WL

Novo Nordisk Investigational Site, Manchester

OX3 7LJ

Novo Nordisk Investigational Site, Oxford